Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults

被引:0
|
作者
Riina A Kekkonen
Marko Sysi-Aho
Tuulikki Seppnen-Laakso
Ilkka Julkunen
Heikki Vapaatalo
Matej Orei
Riitta Korpela
机构
[1] Espoo 02044 Finland
[2] Helsinki 00014 Finland Valio Ltd Research Centre Helsinki 00370 Finland
[3] Helsinki 00300 Finland
[4] National Public Health Institute Department of Viral Diseases and Immunology
[5] University of Helsinki Institute of Biomedicine Pharmacology University of Helsinki
[6] University of Helsinki Institute of Biomedicine Pharmacology University of Helsinki
[7] VTT Technical Research Centre of Finland
基金
芬兰科学院;
关键词
Probiotic; Lactobacillus rhamnosus GG; Lipidomic; Inflammatory mediators; Healthy adults;
D O I
暂无
中图分类号
R589 [代谢病];
学科分类号
1002 ; 100201 ;
摘要
AIM: To investigate the effect of three weeks’ intervention with a probiotic Lactobacillus rhamnosus GG (LGG) bacteria on global serum lipidomic profiles and evaluate whether the changes in inflammatory variables (CRP, TNF-α and IL-6) are reflected in the global lipidomic profiles of healthy adults. METHODS: We performed UPLC/MS-based global lipidomic platform analysis of serum samples (n = 26) in a substudy of a randomised, double-blind, placebo- controlled 3-wk clinical intervention trial investigating the immunomodulatory effects of probiotics in healthy adults. RESULTS: A total of 407 lipids were identified, corresponding to 13 different lipid classes. Serum samples showed decreases in the levels of lysophosphatidylcholines (LysoGPCho), sphingomyelins (SM) and several glycerophosphatidylcholines (GPCho), while triacylglycerols (TAG) were mainly increased in the probiotic LGG group during the intervention. Among the inflammatory variables, IL-6 was moderatelyassociated by changes in global lipidomic profiles, with the top-ranked lipid associated with IL-6 being the proinflammatory LysoGPCho (20:4). There was a weak association between the lipidomic profiles and the two other inflammatory markers, TNF-α and CRP. CONCLUSION: This was the first study to investigate the effects of probiotic intervention on global lipidomic profiles in humans. There are indications that probiotic LGG intervention may lead to changes in serum global lipid profiles, as reflected in decreased GPCho, LysoGPCho and SM as well as mainly increased TAG.
引用
收藏
页码:3188 / 3194
页数:7
相关论文
共 50 条
  • [31] Mucosal Adhesion Properties of the Probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED Pilin Subunits
    von Ossowski, Ingemar
    Reunanen, Justus
    Satokari, Reetta
    Vesterlund, Satu
    Kankainen, Matti
    Huhtinen, Heikki
    Tynkkynen, Soile
    Salminen, Seppo
    de Vos, Willem M.
    Palva, Airi
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2010, 76 (07) : 2049 - 2057
  • [32] Combination of the probiotic Lactobacillus rhamnosus GG with grape antioxidant resveratrol for the management of colorectal cancer
    Singh, Chandra K.
    George, Jasmine
    Duster, Megan
    Safdar, Nasia
    Ahmad, Nihal
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Elucidation of the fucose metabolism of probiotic Lactobacillus rhamnosus GG by metabolomic and flux balance analyses
    Cheong, Yu Eun
    Kim, Jungyeon
    Jin, Yong-Su
    Kim, Kyoung Heon
    JOURNAL OF BIOTECHNOLOGY, 2022, 360 : 110 - 116
  • [34] In Vitro Selection of Antibiotic Resistance in the Probiotic Strain Lactobacillus rhamnosus GG ATCC 53103
    Drago, L.
    Rodighiero, V.
    Mattina, R.
    Toscano, M.
    De Vecchi, E.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (04) : 211 - 215
  • [35] Mechanism of action of gut microbiota and probiotic Lactobacillus rhamnosus GG on skeletal remodeling in mice
    Tyagi, Abdul Malik
    ENDOCRINOLOGY DIABETES & METABOLISM, 2024, 7 (01)
  • [36] In Vivo, In Vitro and Transplacental Immune Effects of a Probiotic Bacterium Lactobacillus rhamnosus GG in Humans
    Boyle, R. J.
    Mah, L.
    Kivivuori, S.
    Chen, A.
    Lahtinen, S. J.
    Robins-Browne, R. M.
    Tang, M. L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S200 - S200
  • [37] Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome
    De Groote, MA
    Frank, DN
    Dowell, E
    Glode, MP
    Pace, NR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (03) : 278 - 280
  • [38] Delay of the first onset of pouchitis by oral intake of the Probiotic strain Lactobacillus rhamnosus GG
    Gosselink, MP
    Schouten, WR
    van Lieshout, LMC
    Hop, WCJ
    Laman, JD
    Ruseler-Van Embden, JGH
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 876 - 884
  • [39] Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis
    Claes, I. J. J.
    Lebeer, Sarah
    Shen, C.
    Verhoeven, T. L. A.
    Dilissen, E.
    De Hertogh, G.
    Bullens, D. M. A.
    Ceuppens, J. L.
    Van Assche, G.
    Vermeire, S.
    Rutgeerts, P.
    Vanderleyden, J.
    De Keersmaecker, S. C. J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (02): : 306 - 314
  • [40] Characterization of anti-apoptotic proteins derived from the probiotic Lactobacillus rhamnosus GG
    Yan, F
    Wilson, G
    John, SK
    Polk, DB
    GASTROENTEROLOGY, 2003, 124 (04) : A106 - A107